At this time, posts about Antrogen are rapidly increasing on portals and stock communities. Antrogen is known as a company that develops and sells stem cell therapeutics.

As of 11:30 AM on the 21st, Antrogen's stock price is 52,700 KRW, up 20.32% from the previous day, with a trading volume of 2,827,023 shares, which is 415.46% of the 5-day average trading volume. On May 20th, Antrogen was a hot topic in the market with the news "Stem cell new drug FDA approval leads to upper limit price increase."

In addition to Antrogen, posts from investors are also surging for Kakao (035720), Doosan Infracore (042670), and Unison (018000).

※Source: AI Investment Assistant AI Rasero

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing